AbbVie (ABBV) EBT (2012 - 2026)

AbbVie has disclosed EBT across 15 years of filings, most recently posting $1.0 billion for Q1 2026.

• In Q1 2026, EBT fell 37.45% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $6.0 billion (up 64.96% YoY), while the FY2025 annual figure was $6.6 billion, up 77.53% from the prior year.
• EBT retreated to $1.0 billion in Q1 2026, from $2.7 billion in the prior quarter.
• Over the last five years, EBT for ABBV reached as high as $4.9 billion in Q1 2022 and fell as low as -$2.3 billion in Q4 2024.
• The 5-year median for EBT is $1.8 billion (2024), against an average of $1.8 billion.
• The widest YoY moves for EBT: up 269.47% in 2024, down 287.21% in 2024.
• A 5-year view of EBT shows it stood at $3.0 billion in 2022, then sank by 59.12% to $1.2 billion in 2023, then slumped by 287.21% to -$2.3 billion in 2024, then soared by 217.58% to $2.7 billion in 2025, then sank by 61.06% to $1.0 billion in 2026.
• According to Business Quant data, EBT over the past three periods registered $1.0 billion, $2.7 billion, and $714.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.